Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease

Keyphrases

• Patients with Coronary Artery Disease 100%
• Diabetic Patients 100%
• Markers of Atherosclerosis 100%
• Thrombosis 100%
• Vildagliptin 100%
• Metformin 100%
• Inflammation Markers 100%
• Dipeptidyl peptidase-4 (DPP-4) 66%
• Blood Samples 33%
• Pharmacological Treatment 33%
• Clinical Significance 33%
• Type 2 Diabetes Mellitus (T2DM) 33%
• Cardiovascular Events 33%
• Clinical Data 33%
• Adipokines 33%
• Interleukin-6 33%
• Interleukin-1β 33%
• High-sensitivity C-reactive Protein (hs-CRP) 33%
• Anti-atherosclerosis 33%
• Atherosclerotic Process 33%
• Dipeptidyl peptidase-4 Inhibition 33%
• Patient's Will 33%
• Antidiabetic Drugs 33%
• 6-high 33%
• Clinical Benefit 33%
• Good Safety 33%
• Platelet Function Tests 33%
• Safety Profile 33%
• Atherothrombotic 33%
• Matrix metalloproteinase-9 (MMP-9) 33%
• Total Adiponectin 33%

Medicine and Dentistry

• Diabetes Mellitus 100%
• Coronary Artery Disease 100%
• Thrombosis 100%
• Atherosclerosis 100%
• Metformin Plus Vildagliptin 100%
• Dipeptidyl Peptidase-4 Inhibitor 100%
• Disease 50%
• Cardiovascular System 50%
• Maturity Onset Diabetes of the Young 50%
• Drug Therapy 50%
• Adiponectin 50%
• Adipocytokine 50%
• Treatment Duration 50%
• Glycon 50%
• Vildagliptin 50%
• C Reactive Protein 50%
• Interleukin 6 50%
• Gelatinase B 50%
• Interleukin 1beta 50%
• Clinical Significance 50%
• Platelet Reactivity 50%
• Dipeptidyl Peptidase IV 50%
• Blood Sampling 50%
• Antidiabetic Agent 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammation 100%
• Diabetes Mellitus 100%
• Coronary Artery Disease 100%
• Thrombosis 100%
• Atherosclerosis 100%
• Dipeptidyl Peptidase IV Inhibitor 100%
• Metformin Plus Vildagliptin 100%
• Disease 50%
• Non Insulin Dependent Diabetes Mellitus 50%
• Adiponectin 50%
• Adipocytokine 50%
• Interleukin 6 50%
• C Reactive Protein 50%
• Vildagliptin 50%
• Metformin 50%
• Antidiabetic Agent 50%
• Interleukin 1beta 50%
• Dipeptidyl Peptidase IV 50%
• Gelatinase B 50%